₹218.40-crore IPO opens to a measured response on Day 1; grey market premium of ₹33 indicates an implied listing price of around ₹163, though GMP remains unofficial and can change
Sun Pharma gets exclusive rights to manufacture and commercialise the once-monthly PCSK9 inhibitor across markets outside the US and China
Pharmaceutical stock climbs to ₹1,228.25 as clean USFDA inspection, strong India and international business prospects and specialty portfolio support investor sentiment.
Volatility gauge jumps nearly 36% in three sessions as Nifty slips below 23,000; rising crude prices, bond yields and geopolitical uncertainty weigh on investor sentiment
Bank of India, Bank of Maharashtra, Union Bank, Canara Bank, PNB and Bank of Baroda decline sharply as rising bond yields, elevated crude prices and inflation concerns pressure banking stocks
Gross office leasing reaches 18.7 million sq ft in July-September, with Bengaluru, Delhi-NCR and Hyderabad driving growth while Mumbai, Pune and Chennai record declines
Jewellery maker completes repayment of outstanding bank debt, strengthening its balance sheet as quarterly performance also shows improvement in sales and profit
Rajiv Anand says he was asked to appear for a hearing to prevent deletion of his name as the Election Commission's Special Intensive Revision exercise continues
Vetri Subramaniam says India's earnings, cash flows and investment cycle remain more important for equity valuations, while investors should focus on diversification and margin of safety